Bill & Melinda Gates Foundation’s “Impatient Optimists”: Connecting the Dots: Advancing Contraceptive R&D through Partnerships and Knowledge Sharing
Laneta Dorflinger, director of contraceptive technology at FHI 360; Kate Rademacher, technical adviser in FHI 360’s global health, population, and nutrition group; and Lucy Wilson, monitoring and evaluation adviser for contraceptive technology innovation at FHI 360, describe the financial and regulatory barriers to advancing new contraceptive methods through the R&D pipeline, as well as the Contraceptive Technology Innovation (CTI) Exchange, a website platform for individuals to share resources and information on contraceptive R&D (7/6).